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OBJECTIVE—Rapid advances in diabetes genetic epidemiology may lead to a new era of
“personalized medicine” based on individual genetic risk assessment. There is minimal experi-
ence to guide how best to clinically implement such testing so that results (e.g., “higher” or
“lower” relativegeneticrisk) improve rather than reducepatient motivation for behavior change.
RESEARCH DESIGN AND METHODS—Between November 2009 and May 2010, we
conductedin-depthinterviewswith22overweightparticipantsathighphenotypicriskfortype2
diabetestoexploreperceptions ofdiabetesgeneticrisktestingcomparedwithcurrentlyavailable
prediction using nongenetic risk factors (e.g., family history, abnormal fasting glucose, obesity).
Weusedhypotheticalscenariostospeciﬁcallyinvestigatetheimpactofboth“higher”and“lower”
relative genetic risk results on participants’ views about diabetes prevention.
RESULTS—Many participants conferred a unique value on personal genetic risk information
relative to nongenetic risk based on the perceived scientiﬁc certainty and durability of genetic
results. In contrast, other participants considered their genetic risk within the overall context of
their other measured risk factors. Reactions to diabetes genetic test results differed by current
motivation levels. Whereas most subjects reported that “higher” risk results would motivate
behavior change, subjects with lower current motivation often reported that “lower” genetic risk
results would further reduce their motivation to engage in diabetes prevention behaviors.
CONCLUSIONS—To be effective, future clinical implementation of type 2 diabetes genetic
risk testing should be individualized based on each patient’s risk perception and current level of
motivation to prevent diabetes.
Diabetes Care 34:568–573, 2011
E
videncefromlandmark clinicaltrials
such as the Diabetes Prevention Pro-
gram has shown that type 2 diabetes
can be prevented in high-risk patients by
lifestyle changes that result in modest
weight loss and increased physical activ-
ity (1,2). Patients can be identiﬁed as at
increased type 2 diabetes risk based on
easily available phenotypic markers
such as fasting glucose levels, abnormal
blood pressure or lipid levels, over-
weight, and family history (3). Despite
available risk stratiﬁcation tools and ef-
fective interventions, however, few pa-
tients successfully adopt and sustain the
lifestyle changes necessary to prevent di-
abetes (4,5).
The contribution of heritable (rather
than environmental) factors to type 2
diabetes has been estimated to be as
high as 40% (6). Current approaches to
deﬁning diabetesrisk using genome-wide
association scans have identiﬁed over
three dozen genetic loci present at .5%
allelic frequency, which are each associ-
ated with a small but signiﬁcant increased
risk for type 2 diabetes (7). At present,
combining all known, validated risk al-
leles provides only modest additional
risk prediction after accounting for
traditional phenotypic risk factors (8–11).
Rapid advances in DNA sequencing tech-
nology, increased ability to identify rare
risk loci, and identiﬁcation of alternative
heritable factors (e.g., copy number varia-
tion, epigenetic marks) hold promise that
future iterations of diabetes genetic risk
testing may provide a more robust assess-
ment of an individual’s heritable risk for
diabetes (12–14).
Despite limitations of current diabetes
genetic testing, the concept of “personalized
genetic proﬁling” has gained increasing
popularity and is a stated focus of re-
search within the National Institutes of
Health (NIH) (15). There are currently
four clinical trials registered with clinical-
trials.gov that are addressing the clinical
implementation of diabetes genetic test-
ing (NCT01034319, NCT00849563,
NCT01060540, NCT01186354). Before
such testing becomes more widely imple-
mented into clinical practice, it is critically
importanttobetterunderstandhowpatients
at risk for diabetes perceive individualized
diabetes genetic risk results (16,17).
The rise of direct-to-consumer ge-
netic testing reﬂects an assumption that
personal genetic information can motivate
healthybehaviorchange(18,19).Although
this assumption remains unproven, a re-
cent survey of patients without type 2 di-
abetes provides some evidence that test
results could motivate patients: nearly
three-quarters (71%) of survey respon-
dents reported that they would be “much
more motivated” to make preventive life-
style changes upon receipt of a higher ge-
netic risk diabetes genetic testing result
(20). This very optimistic anticipated re-
action to genetic test results suggests that
individuals may value genetic risk results
differentlythannongeneticriskresults,al-
though reasonsfor this anticipated impact
arenotclearlyunderstoodandrequirefur-
ther study.
Accurate measurement of an individ-
ual’s diabetes genetic risk could poten-
tially provide signiﬁcant clinical utility
by identifying patients at particularly
high risk for developing type 2 diabetes.
G e n e t i ct e s t i n gm a yb ead o u b l e - e d g e d
sword, however. Although higher genetic
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ORIGINAL ARTICLErisk results may increase perceived risk
andmotivateindividualstoadoptlifestyle
changes, lower genetic risk results may
decrease perceived risk and thus reduce
motivation to adopt healthy lifestyle
changes. Alternatively, higher genetic
risk test results may induce a sense of ge-
neticfatalismthatunderminesmotivation
to change behavior (21).
We conducted in-depth, semistruc-
tured interviews with participants at in-
creased phenotypic risk for diabetes to
gain insight into how they perceived di-
abetes genetic risk information. Partici-
pants were presented with hypothetical
diabetes genetic risk results that placed
them at “higher” or “lower” diabetes ge-
netic risk. Responses were analyzed
within the context of each participant’s
current motivation and attitude toward
diabetes risk reduction. Our study was
designed to 1) investigate whether (and
how) perceptions of genetic risk differed
from traditional phenotypic risk factors
and 2) examine the relationship between
current diabetes prevention behaviors
and response to genetic test results.
RESEARCH DESIGN AND
METHODS
Participants and recruitment
We conducted 22 individual interviews
between November 2009 and May 2010
with patients recruited from the primary
care practices of the Massachusetts Gen-
eral Hospital Practice-based Research
Network (Boston, MA). This practice net-
workincludesafullyfunctionalelectronic
health record and has implemented qual-
ity improvement programs focused on
universal documentation of vital signs.
Eligible participants were at increased
diabetes risk based on meeting criteria
for the metabolic syndrome, deﬁned ev-
idence from the medical record of at least
three out of the ﬁve following: abnormal
glucose results, hypertension, elevated
triglyceride levels, low HDL levels, and
overweight (22). We used medical chart
review and phone screening to exclude
patients with signiﬁcant mental health
problems (e.g., schizophrenia) or other
barriers to effective communication
(e.g., cognitive or language ﬂuency limi-
tations). Patients received a letter co-
signed by their primary care physician
and the study principal investigator
(R.W.G.) inviting them to participate in
the study. To avoid biased selection of
participants with a speciﬁc interest in ge-
netics, the recruitment letter simply
statedthatsubjectswererecruited“topar-
ticipate in a federally-funded research
study to understand patients’ views about
counseling for diabetes risk.” All partici-
pants received a $20 gift card for inter-
view completion. The study protocol
was approved by the Massachusetts Gen-
eral Hospital Institutional Review Board.
Interviews
Structured questions initially elicited par-
ticipants’ views about their risk for devel-
oping diabetes and their motivation to
adopt lifestyle changes for diabetes pre-
vention. Participants were given a brief
descriptionofdiabetesgeneticrisktesting
that purposely avoided using numeric or
scientiﬁc terms (“It recently became pos-
sible to estimate whether a person’si n d i -
vidual genes make him or her at higher or
lower risk for diabetes compared with
other people like them”). We then asked
participants how learning about their in-
dividual genetic risk for diabetes might
affect their motivation and whether they
perceived genetic risk for diabetes to be
differentfromotherkindsofdiabetesrisk.
To speciﬁcally address the contrast
between phenotypic versus genetic risk,
we asked participants to anticipate how
they would react to two clinical testing
scenarios,asfollows.“Pleaseimaginehow
youwouldfeelinthefollowingimaginary
situations: 1) Your doctor tells you that
your risk of developing diabetes is high
compared with other people based on
things like weight and other measure-
ments but lowered because of genetics.
How would this affect your motivation
to reduce your risk for diabetes by im-
proving your diet and exercise over
time? And 2) Your doctor tells you that
your risk of developing diabetes is high
compared with other people based on
things like weight and other measure-
ments and also high because of genetics.
How would this affect your motivation to
reduce your risk for diabetes by improv-
ing your diet and exercise over time?”
After answering these questions, par-
ticipants completed a brief survey that
included a 1–10 scale to rate readiness,
importance, and conﬁdence for diabetes
prevention. We usedthese datato catego-
rize participants as having high or low
motivation to prevent diabetes. For data
analysis, we deﬁned participants who
ranked themselves highly for all three
components (readiness, importance, and
conﬁdence) as the highly motivated
group and participants who reported
lower levels for one or more of the three
components of motivation as the less mo-
tivated group.
Data collection and analysis
Interviews were digitally recorded, tran-
scribed, and reviewed for accuracy and
completeness. All ﬁve study authors par-
ticipated in the analysis process and
initially reviewed the transcripts to iden-
tifymajor concepts.Weidentiﬁedthemes
within each content area and established
that thematiccontentsaturationhad been
reached.Weusedopencodingtodevelop
categories and then reﬁned deﬁnitions
and the content of the codes and com-
pared coding lists. Each interview tran-
script was independently coded by the
leadauthorandatleastoneothermember
of the research team. We then conducted
analysestocompareparticipantswithlow
versus high motivation. At each analysis
phase, the coders compared their results
to resolve discrepancies through discus-
sion and comparison of the raw data.
RESULTS
Study participants
Twenty-two adults (13 men, 9 women)
at increased risk for diabetes participated.
Mean age was 57.7 years, and the major-
ity (14 of 22) had completed college
(Table 1). From coded interviews, we de-
termined that 14 participants were highly
motivated in making or maintaining life-
stylechangesfordiabetesprevention,and
eight were less motivated in making or
maintaining lifestyle changes for diabetes
prevention. Highly motivated partici-
pants were similar in age and education
level, although more likely to be female
and lower income than the less motivated
subjects. Most patients (15 of 22) were
aware of their increased risk for diabetes,
and this awareness did not appear to be
related to motivation levels (Fisher
Pvaluefortheassociationbetweenaware-
nessofincreasedriskfordiabetesandmo-
tivational level = 0.67). No signiﬁcant
differences in components of metabolic
syndrome traits or treatment regimens
were noted between highly motivated
and less motivated participants.
Comparison of highly motivated and
less motivated participants: diabetes
knowledge and current diabetes
prevention behaviors
Study participants were very knowledge-
able about type 2 diabetes and risk fac-
tors for developing the disease, although
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knowledge about how to engage in di-
abetes prevention. Both groups shared a
basic understanding that environmental
factors (e.g., diet and exercise) and heri-
table factors (speciﬁcally, family history)
both contributed to diabetes risk. Despite
this knowledge, some of the participants
in the less motivated group were not
aware of their own risk of developing
diabetes. When asked about the likeli-
hoodofdevelopingdiabetes,forexample,
one participant remarked, “I haven’tt h e
faintest idea,” and another remarked, “I
don’tknow. Ithoughtdiabeteshad some-
thing to do with sugar, too, and ...I’m
not a sugar person.” Several low motiva-
tion group participants explained that
they did not believe themselves to be at
risk because their doctor had never raised
t h ei s s u ew i t ht h e m .A so n ep a r t i c i p a n t
noted, “I’ma tt h ed o c t o r ’s every month,
so if I’m catching on to that, I’dk n o w
about it.”
A major difference between groups
wasthatthehighlymotivatedparticipants
were thinking proactively about diabetes
prevention. Many in the highly motivated
group had already spoken to their doctor
about diabetes and had made speciﬁc
changes to their diet or exercise habits.
In contrast, participants in the less moti-
vatedgroupwereeitherunawarethatthey
were at increased risk for diabetes or were
aware but not actively engaging in di-
abetes prevention. As one participant
explained, “I’m not motivated...I’mn o t
afraid.Idon’tthinkit’satthatpointwhere
I’vegotto,youknow,‘rallythetroopsand
let’s get after it.’” One participant in the
less motivated group expressed fatalism,
stating, “If it happens, it’s going to hap-
pen, and there’s nothing I can do about
it.” Less motivated participants cited
various barriers for not actively working
to prevent diabetes, including failure
with previous weight loss attempts and
lack of awareness of their current risk
for diabetes.
Beliefs about genetic risk information
When asked to compare genetic risk in-
formation with other types of diabetes
risk information, most participants in
both groups expressed that they per-
ceived genetic information to be more
“certain,”“ factual,” or “scientiﬁc” than
phenotypic risk information. Participants
in both groups commented that “there’s
an absolute certainty in genetics,” and
genetic information is “more scientiﬁc”
and the results represents “physical
evidence...coding that is going to make
it easier for me to develop diabetes.” In
contrast, other participants considered
genetic risk information to be of no
greater intrinsic value than other risk in-
formation. Genetic and phenotypic risk
are “two different ways of looking at the
same thing; I wouldn’t separate them.”
Several people commented that genetic
risk information “is just one more piece
of information” and that “it’sa l lp a r to f
t h es a m et h i n g . ”
Impact of genetic testing
Consistent with a prior survey on patient
views about genetic diabetes risk testing
(20), most participants were enthusiastic
aboutthepossibilityofgettingsuchatest.
Reasons for enthusiasm included the an-
ticipation that genetic test results would
more concretely deﬁne their risk and
would help them maintain their level of
motivation. As one participant put it, “It
would be nice to know, so...Iw o u l db e
able to make changes in my diet if I
needed to,” and another said, “if I knew
that I was really at risk to develop it, I
would really want to continue what I was
doing and see if there is any way I can be
trying a little harder.”
Participants in the higher motivation
group were consistently enthusiastic
about diabetes genetic testing. As one
respondent explained, knowing that he
was “genetically predisposed, then it
would be a dramatic change” in his moti-
vation to prevent diabetes. Interest in ge-
netic testing among the less motivated
group ranged from enthusiastic to skepti-
cal. Some participants believed that ge-
netic testing could be very motivating,
such as the participants who commented,
“I think that if I could have that type of
information, I would be much stricter, be-
cause that would be the biggest motivat-
ing factor that I could have,” and, “if they
say, ‘eventually, if you live long enough
you’ll get diabetes,’ I’dd ow h a t e v e rI
could to try to push it back further and
be prepared for it.” Others were more
measured in their response,commenting,
“Iwouldsayalittlebitmore[motivated].I
would start doing it a little bit more than I
dorightnow,”and“Ideﬁnitelywouldput
some credence into it.” Several partici-
pants in the less motivated group also ac-
knowledged that genetic testing for
diabetes could “open their eyes” to the
risk they face and that “it would be one
more thing that would say to me, ‘Hey,
wakeup.’”Oneparticipantdidnotbelieve
genetic testing would be motivating to
him to prevent diabetes, because getting
diabetes is “down the road—there’sj u s t
too many variables,” and he did “not pic-
ture [himself] changing” in response to a
genetic test.
Of interest, participants anticipated
that the beneﬁt of genetic testing would
apply whether the test results were “low”
or “high”. One remarked, “I’ll do every-
thing, no matter what the [genetic] risk
[result] is, to [reduce my risk for diabe-
tes].”Oneparticipantpointedoutthatthe
genetic risk information could also be
valuable to family members, commenting,
“It would be nice to know, so I could tell
my kids.” A few participants also ex-
pressed hesitation related to genetic pri-
vacy. As one subject remarked, “The
problem being, with something like that
is, once you know, what does that do to
your healthcare, insurance risks, and all
that stuff?” There was also concern
about the reliability of the test, such as
the participant who commented, “I
would have to say, ‘how accurate is your
genetic testing?’”
Table 1—Demographics
Patient characteristics
All participants
(n = 22)
Highly motivated
(n =1 4 )
Less highly motivated
(n =8 )
Age, years (SD) 57.7 (10.0) 57.8 (9.9) 57.6 (10.9)
Men 13 (59) 6 (43) 7 (88)
Caucasian 17 (77) 11 (79) 6 (75)
$College education* 17 (77) 17 (77) 6 (75)
Full-time employment 11 (50) 5 (36) 6 (75)
Household income .$50,000* 13 (60) 6 (43) 7 (88)
Aware of diabetes risk 15 (68) 9 (64) 6 (75)
Told of risk by primary care
physician 7 (32) 3 (21) 4 (50)
Data are n (%) unless otherwise indicated. *Indicates one missing data point where the participant omitted
ar e s p o n s e .
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Perceived impact of diabetes genetic risk testingResponse to high versus low genetic
risk scenarios
To better isolate views about genetic risk
from general diabetes risk, participants
were asked to consider two scenarios in
which their doctor informed them that
theywereathighphenotypicriskandhad
received either a high or low personal
genetic risk result for developing diabe-
tes. Many participants in both groups
responded that their motivation to adopt
healthy lifestyle changes to prevent di-
abetes would increase in both situations
because of the high phenotypic risk pres-
ent in both scenarios. As noted by one
participantinthehighlymotivatedgroup,
preventing diabetes “is very important;
whether you’re high or low [genetic
risk], it’s very important.”
In the highly motivated group, many
of whom were already actively engaged in
diabetesprevention,participantsresponded
thatthe“high”geneticriskscenariowould
push them to work harder at diabetes
prevention. Examples of this included:
“I would re-examine where I might be
able tighten things up a little bit,”
“consult a specialist at that point,”“ really
gointohighgear,eatinglessandtrytolose
weight,” and “start making some changes
to further increase the changes that I’m
trying to make, already.” Some partici-
pants in the less motivated group also
found the “high” genetic risk scenario
very motivating, commenting that it
would “make me be totally cognizant of
everything I do, and it would really push
me to be incredibly strict, incredibly pro-
active” and “high in everything, it would
motivate me!” Other participants in the
less motivated group were less enthusias-
tic, but still believed that this situation
“might motivate me a little bit more to
do a little better,”“ would put more ur-
gency toward it; it would give me little
more of a kick,” and cause me to “deal
with it a little more.” One participant in
thisgroupwithafamilyhistoryofdiabetes
noted that he would expect to get a re-
sult that he was at “high” genetic risk and
that it would be “just another piece of
the puzzle to conﬁrm what they’ve been
assuming all along.” There was one indi-
vidual in the less motivated group who
said he did not “think it would” be moti-
vating, because diabetes has “got to be
happening,” to motivate him to take ac-
tion. Another participant in the less moti-
vated group expressed a strong sense
of fatalism that would reduce his motiva-
tion: “Even if you start to exercise you still
can’tc o n v i n c ey o u rm i n dt h a ty o uc a n
overcome what your past generations
have done.”
When asked to respond to the “low”
genetic (but high phenotypic) risk situa-
tion, participants in the less motivated
group had more varied responses than
those in the highly motivated group.
Highly motivated participants said that
they would “still continue doing what I
was doing,” whether because they are
“so afraid of that disease that I will con-
tinue eating the way I do,and exercising,”
or “because I want to lose the weight, not
because of the diabetes.” Some partici-
pants remarked that they might “relax” a
littlemore intermsofdiabetesprevention
but noted that other factors would still
motivate maintaining a healthy lifestyle:
“if the risk was really low, I suppose it
would make me less motivated, but the
sort of things that I am trying to do, I
want to do anyway, not speciﬁcally...to
prevent diabetes.”
Although some participants in the
less motivated group responded similarly
to those in the highly motivated group,
stating“Idon’tthinkIwouldchangewhat
I’m doing at the moment at all,” it is im-
portant to remember that these partici-
pants were currently doing less to
prevent diabetes than the highly moti-
vated group. In response to this scenario,
oneparticipantcommented,“Iwouldstill
be a bit more conscious of what I do, how
I eat and my physical activity, and I think
that would give me a bit more motivation
tochangethethingsthatIcurrentlydo,or
don’td os ow e l l . ” There were, however,
participants in the less motivated group
who remarked that in the low genetic
risk situation, diabetes would become
“one less thing I’ve got to worry about—
not that it would mean that I would say,
‘well, I don’th a v et od oa n y t h i n g . ’” In-
stead, one participant said that because
he “would probably worry less about di-
abetes” he would “worry more about my
bloodpressureandheartandallthephys-
icalthingsthat I haveahigher potential of
happening to me, maybe.” Of concern,
one participant worried that her genetic
testing would reveal “acom pa ra tive lylow
risk and then I’ll say, ‘Oh, ﬁne. I’ll be 300
pounds, who cares?’ Which is not a good
outcome.”
Some participants with a family his-
tory of diabetes noted that they would
expect to have “high” genetic risk, and
that conﬁrmation of this suspicion would
increase motivation, whereas learning
that they were at “low” genetic risk would
reassure them and provide substantial
psychic relief. One participant commented
that getting a “low” genetic risk result
would “make me feel safer, but I would
probably still do the exercise and the
diet.” No participants in either group
reported that they would substantially re-
ducecurrentdiabetespreventionbehavior
inresponsetotheeitherthe“high”or“low”
genetic risk scenario.
CONCLUSIONS—Diabetes genetic
risk testing has been heralded as a poten-
tially useful new clinical tool to motivate
behavior change for diabetes prevention
(23). Although the current state of diabe-
tesgeneticrisktestingislikelyinsufﬁcient
for clinical use, research advances may
lead to an increased ability to deﬁne an
individual’s heritable risk for type 2 dia-
betes. Better insight into how patients
respond to diabetes genetic risk results
can inform how such results should be
communicated to avoid the potential un-
intended consequence of decreasing mo-
tivation to adopt lifestyle changes. To
better understand how patients might in-
terpret personalized diabetes genetic risk
results, we conducted in-depth struc-
tured interviews with subjects at high
phenotypic risk for developing type 2 di-
abetes to assess views regarding the im-
pact of such testing on their approach to
diabetes prevention and to provide a
framework for how diabetes genetic risk
testing might be effectively implemented
into clinical practice in the future.
Our study had two main ﬁndings.
First, we identiﬁed a dichotomy between
study participants who incorporated ge-
netic risk into an overall risk assessment
that included usual factors such as over-
weight and prediabetic fasting glucose
levels versus participants who ascribed a
unique value to personal genetic test
results based on the permanence and
perceived unique value of such testing.
Fortheselatterpatients,thereappearedto
be an intrinsic value to the genetic test
result beyond the simple numeric pre-
sentation of risk. This differential weight-
ing of risk based on measurement source
must be taken into account in future risk
assessment tools and patient communi-
cation strategies.
A second main ﬁnding of our study
was that the impact of the genetic risk
results on reported subsequent behavior
is strongly mediated by baseline levels of
patient motivation (measured as readi-
ness, importance, and conﬁdence in
adopting lifestyle changes to prevent di-
abetes). Whereas highly motivated patients
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spiration from a higher genetic risk result
andwouldnotletalowerriskresultdetract
from their behavioral modiﬁcation goals,
less motivated patients were more likely to
use a lower genetic risk result to reinforce
their decision not to actively engage in
health prevention. This ﬁnding that base-
linemotivationlevelsinﬂuenceresponseto
diabetes genetic test results suggests that
providers should assess their patient’sc u r -
rent knowledge and practice of diabetes
prevention behaviors and motivation to
change these behaviors when disclosing
their diabetes genetic test results.
Type 2 diabetes represents an exam-
pleofacomplexpolygenicdisease(others
include hypertension, asthma, hyperlip-
idemia) that differ from traditional Men-
deliandisordersinthattestresultsconvey
moderate relative genetic risks that 1)
must be incorporated into an overall risk
assessment (including well-deﬁned phe-
notypic risk factors) and 2) can be modi-
ﬁed with behavioral changes. For type 2
diabetes, patients who are identiﬁed as
high risk must make sustained lifestyle
changes (rather than making a single dis-
crete decision, as with most other genetic
testing paradigms) to prevent disease on-
set. Because diabetes prevention is not a
single act or decision, but rather a contin-
uous daily effort to eat healthy foods, get
adequate physical exercise, and lose
weight and/or maintain weight loss, pa-
tients must maintain their motivation
for a long period of time. Genetic risk is
correctly perceived as unmodiﬁable, and
for some patients this persistent risk pro-
vides ongoing motivation independent of
changes or ﬂuctuations in their modiﬁ-
able risk factors. Given that all patients
with high phenotypic risk for diabetes
wouldbeneﬁtfr omimp rove dd ieta ndin-
creased exercise, we propose that if dia-
betes genetic risk testing becomes a part
of clinical practice, test result disclosure
(whether “higher” or “lower” relative ge-
netic risk result) represents a potential
“teachable moment” for both assessing
andmotivatingbehaviorchange.Thusre-
sultdisclosureshouldbe accompaniedby
counseling that both explains genetic risk
(traditional genetic counseling) and also
links the test result to subsequent behav-
ior change (traditional diabetes preven-
tion counseling).
Strengths and limitations
This study had several strengths. We
contrasted results based on a multidi-
mensional measure of motivation that
quantitatively assessed three related mo-
tivation domains: readiness, importance,
and conﬁdence (24). Dichotomizing our
participants by their baseline motivation
allowed us to highlight the key role of cur-
rent behaviors in mediating how diabetes
genetic risk information is understood.
Moreover, by presenting patients with
two scenarios that explicitly contrasted
“higher” versus “lower” diabetes genetic
risk results in the speciﬁc context of in-
creased phenotypic risk, we were able to
isolate patient perceptions of the unique
value of genetic risk results.
Participants were generally well edu-
cated. Further research involving partic-
ipants with lower literacy and numeracy
skills may provide additional key insights
into how diabetes genetic risks would be
interpreted and how such testing should
be clinically implemented in the future.
Practice implications
Preventing diabetes requires motivation
and commitment to make sustained life-
style changes, including increasing phys-
ical activity and careful attention to
dietary intake. Our study demonstrates
that type 2 diabetes genetic risk testing
may play a role in motivating patients to
initiate or intensify lifestyle changes. For
more motivated patients who were al-
ready making lifestyle changes, genetic
testing results indicating a higher relative
risk appeared to increase their sense of
urgency to intensify healthy lifestyle be-
haviors, whereas lower risk results were
not likely to reduce current preventive
behaviors. For some less motivated pa-
tients, genetic testing results that con-
ferred higher genetic risk seemed to
represent a greater certainty of risk that
lessened denial and increased feelings of
vulnerability and urgency to prioritize
action. However, lower risk results may
have the unintended consequence of un-
dermining motivation to adopt healthy
lifestyle changes. To optimize motivation
in these patients, the decision to under-
take diabetes genetic risk testing should
be linked with opportunity to enroll in a
lifestyle intervention program to provide
the structure, education, skills, and sup-
port necessary to facilitate sustainable
lifestyle changes for diabetes prevention.
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